Literature DB >> 28359822

Computational and experimental approaches for development of methotrexate nanosuspensions by bottom-up nanoprecipitation.

Aline Martins Dos Santos1, Flávia Chiva Carvalho2, Deiver Alessandro Teixeira3, David Lima Azevedo4, Wander Miguel de Barros3, Maria Palmira Daflon Gremião5.   

Abstract

Development of nanosuspensions offers a promising tool for formulations involving poorly water-soluble drugs. In this study, methotrexate (MTX) nanosuspensions were prepared using a bottom-up process based on acid-base neutralization reactions. Computational studies were performed to determine structural and electronic properties for isolated molecules and molecular clusters in order to evaluate the mechanism of MTX nanoparticle formation. Computational results indicated that the clusters in zwitterionic and cationic states presented larger dimensions and higher energies of interaction between MTX molecules, which favored aggregation. In contrast, the clusters in the anionic state exhibited lower energies of interaction, indicating aggregation was less likely to occur. Experimental results indicated that the higher the HCl proportion during drug precipitation, the greater the particle size, resulting in micrometric particles (2874-7308nm) (cationic and zwitterionic forms). However, MTX nanoparticles ranging in size from 132 to 186nm were formed using the lowest HCl proportion during drug precipitation (anionic form). In vitro release profiles indicated that the drug release rate from nanosuspension was increased (approximately 2.6 times) over that of the raw material. Overall, computational modeling and experimental analysis were complementary and assisted in the rational design of the nanosuspension based on acid-base reactions.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acid-base neutralization; Bottom-up process; Computational modeling; Methotrexate; Nanosuspensions

Mesh:

Substances:

Year:  2017        PMID: 28359822     DOI: 10.1016/j.ijpharm.2017.03.068

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  High Efficacy Combined Microneedles Array with Methotrexate Nanocrystals for Effective Anti-Rheumatoid Arthritis.

Authors:  Fang Wei; Qiuyue Wang; Hang Liu; Xuejing Yang; Wenyu Cao; Weiman Zhao; Yingying Li; Lijie Zheng; Tao Ma; Qingqing Wang
Journal:  Int J Nanomedicine       Date:  2022-05-24

2.  Development of Methotrexate Complexes Endowed with New Biological Properties Envisioned for Musculoskeletal Regeneration in Rheumatoid Arthritis Environments.

Authors:  Daniel Fernández-Villa; Rosa Ana Ramírez-Jiménez; Inmaculada Aranaz; Niuris Acosta; Blanca Vázquez-Lasa; Luis Rojo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

3.  Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.

Authors:  Do-Hoon Kuk; Eun-Sol Ha; Dong-Hyun Ha; Woo-Yong Sim; Seon-Kwang Lee; Ji-Su Jeong; Jeong-Soo Kim; In-Hwan Baek; Heejun Park; Du Hyung Choi; Jin-Wook Yoo; Seong Hoon Jeong; Sung-Joo Hwang; Min-Soo Kim
Journal:  Pharmaceutics       Date:  2019-12-17       Impact factor: 6.321

4.  Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis.

Authors:  Ismaiel A Tekko; Andi Dian Permana; Lalitkumar Vora; Taher Hatahet; Helen O McCarthy; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2020-07-15       Impact factor: 4.384

5.  Synthesis of Two Methotrexate Prodrugs for Optimizing Drug Loading into Liposomes.

Authors:  Valentina Di Francesco; Martina Di Francesco; Paolo Decuzzi; Roberto Palomba; Miguel Ferreira
Journal:  Pharmaceutics       Date:  2021-03-04       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.